1-20 of 93
Thomas R. Collins
Close
Sort by
News

Ibrutinib-Venetoclax Combination Shows High Rate of Response in Patients With Treatment-Naïve MCL

Free
Thomas R. Collins
Published: 2025
Abstract
July 2025
View News titled, Ibrutinib-Venetoclax Combination Shows High Rate of Response in Patients With Treatment-Naïve MCL
News

Isatuximab-Based Quad Therapy Delivers Improved MRD Negativity in NDMM

Free
Thomas R. Collins
Published: 2025
Abstract
July 2025
View News titled, Isatuximab-Based Quad Therapy Delivers Improved MRD Negativity in NDMM
News

Real-World Venetoclax Combinations for MM Show Evidence of Efficacy in Patients Harboring t(11;14)

Free
Thomas R. Collins
Published: 2025
Abstract
June 2025
View News titled, Real-World Venetoclax Combinations for MM Show Evidence of Efficacy in Patients Harboring t(11;14)
News

MRD-Guided Approaches Yield Good Results With IsaKRD in MM

Free
Thomas R. Collins
Published: 2025
Abstract
June 2025
View News titled, MRD-Guided Approaches Yield Good Results With IsaKRD in MM
News

Cell-of-Origin, CNS-IPI Scores Help Predict Secondary CNS Lymphoma Risk in DLBCL

Free
Thomas R. Collins
Published: 2025
Abstract
June 2025
View News titled, Cell-of-Origin, CNS-IPI Scores Help Predict Secondary CNS Lymphoma Risk in DLBCL
News

PVEK Shows Promising Efficacy in Blastic Plasmacytoid Dendritic Cell Neoplasm

Free
Thomas R. Collins
Published: 2025
Abstract
July 2025
View News titled, PVEK Shows Promising Efficacy in Blastic Plasmacytoid Dendritic Cell Neoplasm
News

Patients With R/R CLL/SLL Achieve Tumor Response With DZD8586

Free
Thomas R. Collins
Published: 2025
Abstract
July 2025
View News titled, Patients With R/R CLL/SLL Achieve Tumor Response With DZD8586
News

Zanubrutinib Plus Venetoclax Shows Efficacy in Treatment-Naïve CLL/SLL

Free
Thomas R. Collins
Published: 2025
Abstract
July 2025
View News titled, Zanubrutinib Plus Venetoclax Shows Efficacy in Treatment-Naïve CLL/SLL
News

Analysis Offers Insight Into CAR-T-Related Secondary Malignancies

Free
Thomas R. Collins
Published: 2025
Abstract
June 2025
View News titled, Analysis Offers Insight Into CAR-T-Related Secondary Malignancies
News

Daratumumab-Containing Quadruplet Effective as First-Line in Transplant-Ineligible NDMM, Randomized Trial Finds

Free
Thomas R. Collins
Published: 2025
Abstract
May 2025
View News titled, Daratumumab-Containing Quadruplet Effective as First-Line in Transplant-Ineligible NDMM, Randomized Trial Finds
News

Lenalidomide Maintenance Discontinuation a Viable Option for Some Patients With MM

Free
Thomas R. Collins
Published: 2025
Abstract
May 2025
View News titled, Lenalidomide Maintenance Discontinuation a Viable Option for Some Patients With MM
News

Short-Term Benefit Seen With Tranexamic Acid in Hemarthrosis, but Questions Persist

Free
Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Short-Term Benefit Seen With Tranexamic Acid in Hemarthrosis, but Questions Persist
News

New Tool Aims to Improve Capture of Patient Outcomes in cGVHD-Associated Sclerosis

Free
Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, New Tool Aims to Improve Capture of Patient Outcomes in cGVHD-Associated Sclerosis
News

Telemedicine Approach Helps Improve IC-Based SCD Pain Management

Free
Thomas R. Collins
Published: 2025
Abstract
March 2025
View News titled, Telemedicine Approach Helps Improve IC-Based SCD Pain Management
News

Teclistamab Safe for Treating Patients with R/R MM with Renal Impairment

Free
Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Teclistamab Safe for Treating Patients with R/R MM with Renal Impairment
News

Extramedullary Disease Helps Predict Immune Effector Cell Toxicities After CAR-T in MM

Free
Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Extramedullary Disease Helps Predict Immune Effector Cell Toxicities After CAR-T in MM
News

Physical Function Can Help Gauge ICANS Risk, Study Finds

Free
Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Physical Function Can Help Gauge ICANS Risk, Study Finds
News

Multimodal Machine Learning Boosts CAR-T Outcome Prediction in LBCL

Free
Thomas R. Collins
Published: 2025
Abstract
April 2025
View News titled, Multimodal Machine Learning Boosts CAR-T Outcome Prediction in LBCL
News

IL-15 Agonist Boosts Response in Phase II LBCL CAR-T Trial

Free
Thomas R. Collins
Published: 2025
Abstract
February 2025
View News titled, IL-15 Agonist Boosts Response in Phase II LBCL CAR-T Trial
News

CAR-T Produces Good Long-Term Outcomes in R/R CLL, Analysis Finds

Free
Thomas R. Collins
Published: 2024
Abstract
January 2025
View News titled, CAR-T Produces Good Long-Term Outcomes in R/R CLL, Analysis Finds